| Authors: |
Bergamini A; Department of Medical Oncology, Charing Cross Hospital, London, UK.; Department of Obstetrics and Gynecology, San Raffaele Hospital, Milano, Lombardia, Italy., Ramaswami R; Department of Medical Oncology, Charing Cross Hospital, London, UK., Froeling F; Department of Medical Oncology, Charing Cross Hospital, London, UK.; Wolfson Wohl Cancer Research Centre and Beatson West of Scotland Cancer Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK., Papanastasopoulos P; Department of Medical Oncology, Charing Cross Hospital, London, UK., Short D; Department of Medical Oncology, Charing Cross Hospital, London, UK., Aguiar X; Department of Medical Oncology, Charing Cross Hospital, London, UK., Savage PM; Department of Medical Oncology, Charing Cross Hospital, London, UK.; Department of Medical Oncology, Brighton and Sussex University Hospitals NHS Trust, Worthing, UK., Sarwar N; Department of Medical Oncology, Charing Cross Hospital, London, UK., Kaur B; Department of Medical Oncology, Charing Cross Hospital, London, UK.; Department of Histopathology, Charing Cross Hospital, London, UK., Saso S; Department of Gynecologic Oncology, Hammersmith Hospitals NHS Trust, London, UK., Fotopoulou C; Department of Gynecologic Oncology, Hammersmith Hospitals NHS Trust, London, UK., Sharma A; Department of Medical Oncology, Mount Vernon and Watford NHS Trust, Watford, UK., Rustin GJS; Department of Medical Oncology, Mount Vernon and Watford NHS Trust, Watford, UK., Seckl M; Department of Medical Oncology, Charing Cross Hospital, London, UK m.seckl@imperial.ac.uk. |
